Bullish on Ipca Lab, see strong earnings growth: Rajesh Kothari

Rajesh Kothari, Managing Director at AlfAccurate Advisors told CNBC-TV18, "In pharmaceuticals, we need to be completely bottom-up because every company's business model is different and the products and kind of opportunities are also different. So, in pharmaceuticals right now, what we have been bullish on is Ipca Laboratories, which we are holding on from probably the last quarter or so.""We have added Glenmark Pharma to our portfolio. Kindly put a disclaimer because we are holding for our clients. So, we are very selective when it comes to pharmaceutical space because uncertainty for US Food and Drug Administration (FDA) kind of thing, it continues to remain very heavily on the pharmaceutical companies. These are the two companies where we believe the valuations are quite reasonable and the earnings growth can be very strong over the next 2-3 years," he said.